文献
J-GLOBAL ID:202002213041921792
整理番号:20A0407358
MET陽性固形腫瘍患者におけるカプマチニブの第一相試験:用量増加と選択したコホートの拡大
Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohorts
著者 (16件):
Bang Yung-Jue
(Seoul National University College of Medicine, Seoul, Korea)
,
Su Wu-Chou
(National Cheng Kung University Hospital, Tainan, Taiwan)
,
Schuler Martin
(Department of Medical Oncology, West German Cancer Center, University Duisburg-Essen and German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany)
,
Nam Do-Hyun
(Samsung Medical Center, Seoul, Korea)
,
Lim Wan Teck
(National Cancer Centre, Singapore)
,
Bauer Todd M.
(Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, Tennessee, USA)
,
Azaro Analia
(Department of Medical Oncology, Molecular Therapeutics Research Unit, Vall d’Hebron University Hospital, Barcelona, Spain)
,
Azaro Analia
(Pharmacology Department, The Autonomous University of Barcelona, (UAB), Barcelona, Spain)
,
Poon Ronnie Tung Ping
(Queen Mary Hospital, Hong Kong, China)
,
Hong David
(University of Texas/MD Anderson Cancer Center, Houston, Texas, USA)
,
Lin Chia-Chi
(National Taiwan University Hospital, Taipei, Taiwan)
,
Akimov Mikhail
(Novartis Pharma AG, Basel, Switzerland)
,
Ghebremariam Samson
(Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA)
,
Zhao Sylvia
(China Novartis Institutes for BioMedical Research, Shanghai, China)
,
Giovannini Monica
(Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA)
,
Ma Brigette
(State Key Laboratory of Translational Oncology, Phase 1 Clinical Trial Centre, The Chinese University of Hong Kong, Hong Kong, China)
資料名:
Cancer Science (Web)
(Cancer Science (Web))
巻:
111
号:
2
ページ:
536-547
発行年:
2020年
JST資料番号:
U0505A
ISSN:
1349-7006
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)